These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 9803612
41. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F. Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062 [Abstract] [Full Text] [Related]
42. HDV infection in Cyprus. Eleftheriou A, Teloni F, Ioannou P. Prog Clin Biol Res; 1993 Nov; 382():277-85. PubMed ID: 8502692 [No Abstract] [Full Text] [Related]
43. Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. Ojo OS, Thursz M, Thomas HC, Ndububa DA, Adeodu OO, Rotimi O, Lawal AA, Durosinmi MA, Akonai AK, Fatusi AO. East Afr Med J; 1995 Nov; 72(11):719-21. PubMed ID: 8904063 [Abstract] [Full Text] [Related]
44. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. Devi KhS, Singh NB, Singh HL, Singh YM. J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379 [Abstract] [Full Text] [Related]
45. [The prevalence and clinical characteristics of hepatitis-delta infection in Korea]. Jeong SH, Kim JM, Ahn HJ, Park MJ, Paik KH, Choi W, Kim J, Han CJ, Kim YC, Lee JO, Hong YJ, Park HY, Jeong HH, Yoon MY, Lee M, Lee KH. Korean J Hepatol; 2005 Mar; 11(1):43-50. PubMed ID: 15788884 [Abstract] [Full Text] [Related]
46. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M. Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941 [Abstract] [Full Text] [Related]
47. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Navascués CA, Rodríguez M, Sotorrío NG, Sala P, Linares A, Suárez A, Rodrigo L. Am J Gastroenterol; 1995 Nov; 90(11):1981-4. PubMed ID: 7485005 [Abstract] [Full Text] [Related]
48. Antibodies to hepatitis B virus and hepatitis C virus in residential detoxification clients in Jamaica. Smikle MF, Dowe G, Williams EM, Thesiger C. Hum Antibodies; 2000 Nov; 9(4):231-3. PubMed ID: 11341177 [Abstract] [Full Text] [Related]
50. Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia State prisoners. Tucker RM, Gaffey MJ, Fisch MJ, Kaiser DL, Guerrant RL, Normansell DE. Clin Ther; 1987 Oct; 9(6):622-8. PubMed ID: 3440274 [Abstract] [Full Text] [Related]
51. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Mansour-Ghanaei F, Fallah MS, Shafaghi A, Yousefi-Mashhoor M, Ramezani N, Farzaneh F, Nassiri R. Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038 [Abstract] [Full Text] [Related]
52. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR. Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299 [Abstract] [Full Text] [Related]
53. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre. Das K, Ali H, Mahmood T, Munir SM, Ahmed T, Farooq MU. J Ayub Med Coll Abbottabad; 2008 Sep; 20(2):39-42. PubMed ID: 19385455 [Abstract] [Full Text] [Related]
54. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts. Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B. Ig Sanita Pubbl; 2005 Sep; 61(5):435-50. PubMed ID: 17214028 [Abstract] [Full Text] [Related]
55. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization. Tsatsralt-Od B, Takahashi M, Endo K, Agiimaa D, Buyankhuu O, Ninomiya M, Lorenzo FR, Okamoto H. J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839 [Abstract] [Full Text] [Related]
56. Hepatitis C virus infections in oral and injectable drug users. Woodfield DG, Harness M, Rix-Trott K. N Z Med J; 1993 Aug 11; 106(961):332-4. PubMed ID: 8341473 [Abstract] [Full Text] [Related]
57. Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador. Ratnam S, Head CB, Butler RW. CMAJ; 1986 Apr 15; 134(8):905-7. PubMed ID: 3955485 [Abstract] [Full Text] [Related]
58. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Cenac A, Pedroso ML, Djibo A, Develoux M, Pichoud C, Lamothe F, Trepo C, Warter A. Am J Trop Med Hyg; 1995 Apr 15; 52(4):293-6. PubMed ID: 7537942 [Abstract] [Full Text] [Related]
60. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey. Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME, Goral V. Intervirology; 2007 Apr 15; 50(2):133-7. PubMed ID: 17191015 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]